de US Bancorp Invesco Biotechnology & Genome ETF PBE Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 1.48 M | Mantener |
16,500
| – | – | ﹤0.01% | 1021 |
|
|
2026
Q1 | USD 1.31 M | Mantener |
16,500
| – | – | ﹤0.01% | 1033 |
|
|
2025
Q4 | USD 1.36 M | Mantener |
16,500
| – | – | ﹤0.01% | 1031 |
|
|
2025
Q3 | USD 1.15 M | Mantener |
16,500
| – | – | ﹤0.01% | 1076 |
|
|
2025
Q2 | USD 1.06 M | Mantener |
16,500
| – | – | ﹤0.01% | 1091 |
|
|
2025
Q1 | USD 1.05 M | Mantener |
16,500
| – | – | ﹤0.01% | 1091 |
|
|
2024
Q4 | USD 1.1 M | Mantener |
16,500
| – | – | ﹤0.01% | 1087 |
|
|
2024
Q3 | USD 1.15 M | Vender |
16,500
-300
| -2% | -USD 20.8 k | ﹤0.01% | 1070 |
|
|
2024
Q2 | USD 1.09 M | Mantener |
16,800
| – | – | ﹤0.01% | 1064 |
|
|
2024
Q1 | USD 1.09 M | Comprar |
16,800
+300
| +2% | +USD 19.5 k | ﹤0.01% | 1079 |
|
|
2023
Q4 | USD 1.09 M | Mantener |
16,500
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q3 | USD 941 k | Mantener |
16,500
| – | – | ﹤0.01% | 1090 |
|
|
2023
Q2 | USD 1.01 M | Mantener |
16,500
| – | – | ﹤0.01% | 1067 |
|
|
2023
Q1 | USD 1.04 M | Mantener |
16,500
| – | – | ﹤0.01% | 1061 |
|
|
2022
Q4 | USD 1.05 M | Mantener |
16,500
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q3 | USD 973 k | Vender |
16,500
-465
| -3% | -USD 28.7 k | ﹤0.01% | 1069 |
|
|
2022
Q2 | USD 980 k | Mantener |
16,965
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q1 | USD 1.05 M | Mantener |
16,965
| – | – | ﹤0.01% | 1157 |
|
|
2021
Q4 | USD 1.21 M | Mantener |
16,965
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q3 | USD 1.27 M | Mantener |
16,965
| – | – | ﹤0.01% | 1072 |
|
|
2021
Q2 | USD 1.31 M | Mantener |
16,965
| – | – | ﹤0.01% | 1064 |
|
|
2021
Q1 | USD 1.25 M | Mantener |
16,965
| – | – | ﹤0.01% | 1040 |
|
|
2020
Q4 | USD 1.19 M | Mantener |
16,965
| – | – | ﹤0.01% | 1022 |
|
|
2020
Q3 | USD 961 k | Vender |
16,965
-5,500
| -24% | -USD 323 k | ﹤0.01% | 1019 |
|
|
2020
Q2 | USD 1.31 M | Mantener |
22,465
| – | – | ﹤0.01% | 848 |
|
|
2020
Q1 | USD 1.04 M | Mantener |
22,465
| – | – | ﹤0.01% | 891 |
|
|
2019
Q4 | USD 1.26 M | Mantener |
22,465
| – | – | ﹤0.01% | 957 |
|
|
2019
Q3 | USD 1.06 M | Mantener |
22,465
| – | – | ﹤0.01% | 1003 |
|
|
2019
Q2 | USD 1.2 M | Mantener |
22,465
| – | – | ﹤0.01% | 998 |
|
|
2019
Q1 | USD 1.24 M | Mantener |
22,465
| – | – | ﹤0.01% | 971 |
|
|
2018
Q4 | USD 1.06 M | Mantener |
22,465
| – | – | ﹤0.01% | 982 |
|
|
2018
Q3 | USD 1.34 M | Mantener |
22,465
| – | – | ﹤0.01% | 967 |
|
|
2018
Q2 | USD 1.23 M | Mantener |
22,465
| – | – | ﹤0.01% | 1004 |
|
|
2018
Q1 | USD 1.11 M | Comprar |
22,465
+220
| +1% | +USD 11.2 k | ﹤0.01% | 1037 |
|
|
2017
Q4 | USD 1.05 M | Mantener |
22,245
| – | – | ﹤0.01% | 1080 |
|
|
2017
Q3 | USD 1.11 M | Mantener |
22,245
| – | – | ﹤0.01% | 1028 |
|
|
2017
Q2 | USD 1.02 M | Mantener |
22,245
| – | – | ﹤0.01% | 1048 |
|
|
2017
Q1 | USD 941 k | Vender |
22,245
-825
| -4% | -USD 34.6 k | ﹤0.01% | 1106 |
|
|
2016
Q4 | USD 895 k | Vender |
23,070
-604
| -3% | -USD 24.4 k | ﹤0.01% | 1121 |
|
|
2016
Q3 | USD 993 k | Comprar |
23,674
+329
| +1% | +USD 13.5 k | ﹤0.01% | 1032 |
|
|
2016
Q2 | USD 864 k | Vender |
23,345
-190
| -0.8% | -USD 7.45 k | ﹤0.01% | 1083 |
|
|
2016
Q1 | USD 901 k | Vender |
23,535
-235
| -1% | -USD 9.13 k | ﹤0.01% | 1029 |
|
|
2015
Q4 | USD 1.2 M | Comprar |
23,770
+100
| +0.4% | +USD 4.94 k | ﹤0.01% | 873 |
|
|
2015
Q3 | USD 1.08 M | Vender |
23,670
-610
| -3% | -USD 34.1 k | ﹤0.01% | 921 |
|
|
2015
Q2 | USD 1.42 M | Vender |
24,280
-50
| -0.2% | -USD 2.86 k | 0.01% | 846 |
|
|
2015
Q1 | USD 1.34 M | Vender |
24,330
-200
| -0.8% | -USD 10.8 k | 0.01% | 881 |
|
|
2014
Q4 | USD 1.23 M | Vender |
24,530
-280
| -1% | -USD 13.7 k | ﹤0.01% | 915 |
|
|
2014
Q3 | USD 1.15 M | Mantener |
24,810
| – | – | ﹤0.01% | 932 |
|
|
2014
Q2 | USD 1.08 M | Mantener |
24,810
| – | – | ﹤0.01% | 967 |
|
|
2014
Q1 | USD 1.03 M | Comprar |
24,810
+610
| +3% | +USD 26.1 k | ﹤0.01% | 963 |
|
|
2013
Q4 | USD 897 k | Mantener |
24,200
| – | – | ﹤0.01% | 979 |
|
|
2013
Q3 | USD 849 k | Mantener |
24,200
| – | – | ﹤0.01% | 961 |
|
|
2013
Q2 | USD 700 k | Comprar |
+24,200
| Nuevas | +USD 688 k | ﹤0.01% | 998 |
|
Otros fondos que tienen PBE en su cartera
Posición de US Bancorp en PBE: resumen de T2 2026
US Bancorp mantuvo sin cambios su posición en Invesco Biotechnology & Genome ETF (PBE) en T2 2026, con 16,500 acciones por un valor de USD 1.48 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1021.
US Bancorp reportó por primera vez una posición en PBE en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 104 fondos que sigue Wall St. Rank mantienen una posición en PBE.
- Al cierre de T2 2026, US Bancorp tenía 16,500 acciones de Invesco Biotechnology & Genome ETF con un valor de USD 1.48 M.
- US Bancorp mantuvo sin cambios su número de acciones de Invesco Biotechnology & Genome ETF en T2 2026.
- Invesco Biotechnology & Genome ETF representó ﹤0.01% de la cartera de US Bancorp en T2 2026 y fue su posición número 1021.
- US Bancorp reportó por primera vez una posición en Invesco Biotechnology & Genome ETF en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 104 fondos que sigue Wall St. Rank tenían Invesco Biotechnology & Genome ETF en cartera.
Según el Informe 13F de US Bancorp correspondiente a T2 2026, presentado el 12 ago 2026.